Private Capital Advisors’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,083
| Closed | -$83K | – | 99 |
|
|
2022
Q4 | $83K | Hold |
13,083
| – | – | 0.01% | 76 |
|
|
2022
Q3 | $67K | Hold |
13,083
| – | – | 0.01% | 80 |
|
|
2022
Q2 | $82K | Hold |
13,083
| – | – | 0.01% | 82 |
|
|
2022
Q1 | $46K | Hold |
13,083
| – | – | 0.01% | 94 |
|
|
2021
Q4 | $66K | Hold |
13,083
| – | – | 0.01% | 81 |
|
|
2021
Q3 | $96K | Hold |
13,083
| – | – | 0.02% | 94 |
|
|
2021
Q2 | $112K | Hold |
13,083
| – | – | 0.02% | 91 |
|
|
2021
Q1 | $142K | Hold |
13,083
| – | – | 0.03% | 96 |
|
|
2020
Q4 | $129K | Sell |
13,083
-1
| -0% | -$7 | 0.03% | 92 |
|
|
2020
Q3 | $70K | Hold |
13,084
| – | – | 0.02% | 89 |
|
|
2020
Q2 | $77K | Hold |
13,084
| – | – | 0.02% | 83 |
|
|
2020
Q1 | $49K | Hold |
13,084
| – | – | 0.02% | 72 |
|
|
2019
Q4 | $83K | Hold |
13,084
| – | – | 0.02% | 79 |
|
|
2019
Q3 | $180K | Hold |
13,084
| – | – | 0.05% | 86 |
|
|
2019
Q2 | $193K | Hold |
13,084
| – | – | 0.05% | 91 |
|
|
2019
Q1 | $549K | Hold |
13,084
| – | – | 0.17% | 64 |
|
|
2018
Q4 | $544K | Hold |
13,084
| – | – | 0.2% | 59 |
|
|
2018
Q3 | $631K | Hold |
13,084
| – | – | 0.17% | 70 |
|
|
2018
Q2 | $620K | Hold |
13,084
| – | – | 0.19% | 62 |
|
|
2018
Q1 | $805K | Hold |
13,084
| – | – | 0.27% | 59 |
|
|
2017
Q4 | $703K | Hold |
13,084
| – | – | 0.24% | 64 |
|
|
2017
Q3 | $881K | Sell |
13,084
-979
| -7% | -$56.1K | 0.3% | 55 |
|
|
2017
Q2 | $762K | Buy |
14,063
+4,688
| +50% | +$217K | 0.25% | 75 |
|
|
2017
Q1 | $334K | Buy |
+9,375
| New | +$321K | 0.11% | 101 |
|
Private Capital Advisors's FSTX Position: Q1 2023 in Review
Private Capital Advisors sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 13,083 shares — an estimated $83K sold.
Private Capital Advisors first reported a position in FSTX in Q1 2017 and held it in 24 quarters. The position peaked at $881K in Q3 2017. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Private Capital Advisors reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Private Capital Advisors sold 13,083 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $83K.
- Private Capital Advisors first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2017 and held it in 24 quarters.
- Private Capital Advisors's F-star Therapeutics, Inc. Common Stock position peaked at $881K in Q3 2017.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Private Capital Advisors's 13F filing for Q1 2023, filed 8 May 2023.